N[uclear]{.smallcaps} protein import in eukaryotic cells occurs through openings in the nuclear envelope that are spanned by nuclear pore complexes (NPC)^1^ ([@B18]; [@B60]) and is characterized by an energy requirement, signal dependence, and receptor involvement. In vitro assays using semipermeabilized cells have allowed the identification of the soluble factors essential for nuclear protein import ([@B2]; [@B48]; [@B40]), and studies of their interactions with each other and with nuclear pore proteins have led to models of the protein import pathway that suggest several distinct steps. In the cytoplasm, the α subunit of the karyopherin heterodimer, also called importin α, recognizes the nuclear localization signal (NLS) (for review see [@B15]; [@B20]) of a karyophilic protein in a temperature- and hence energy-independent manner. Subsequently the karyopherin β subunit mediates docking of the complex to the cytoplasmic periphery of the nuclear pore ([@B1]; [@B24], [@B25]; [@B31],*b*; [@B43],*b*; [@B56]; [@B66]). Ran, a member of the Ras superfamily of guanine nucleotide binding proteins, binds in its GTP form to RanBP2 close to this initial docking site ([@B39]). GTP hydrolysis of RanGTP, which has been shown to be necessary for translocation of the import substrate ([@B37]; [@B41]; [@B61]), occurs at the same site and probably allows the undocking of the karyopherin/substrate complex. This GTP hydrolysis is stimulated by RanGAP1 at the nuclear envelope ([@B6], [@B7],*b*; [@B11]; [@B36]; [@B35]). Possible links between Ran and the karyopherin/substrate complex are pp15 ([@B29]; [@B42]; [@B53]; [@B47]; [@B54]) and RanBP1 ([@B10]). The import complex is proposed to move to the immediate vicinity of the nuclear pore before translocation into the nucleus via several binding sites for pp15 and karyopherin β ([@B44]; [@B53]; [@B56]; [@B47]).

It is likely that all of the soluble transport factors mentioned above enter the nucleus in a complex with the cargo protein, although this has not been demonstrated directly. While karyopherin β remains bound to the nuclear side of the NPC and is very rapidly reexported ([@B26]; [@B44]), the transport substrate, karyopherin α, RanGDP, and pp15 appear to enter the nucleoplasm. However, it is not known how or when the dissociation of the import complex is induced. Considering that directionality must be maintained during transport, dissociation may occur solely as the termination step of the import reaction in the nucleus ([@B38]; [@B23]). Alternatively, reiterated dissociation and association reactions may occur during translocation through the pore ([@B58]; [@B28]). Recent data show that RanGTP destabilizes the αβ-heterodimer of karyopherin ([@B58]). Exchange of GDP for GTP on Ran in the nucleus could therefore induce the dissociation of the import complex. The now free import substrate would be retained in the nucleus by association with, for example, DNA or chromatin, while the import factors could be recycled. The GDP/GTP exchange factor for Ran in the nucleus is RCC1 (regulator of chromosome condensation) ([@B4],*b*; for review see [@B13]), first identified as the mutant gene in tsBN2 cells, a thermosensitive mutant line derived from BHK21 cells ([@B50]; [@B51]).

The mechanism by which the NLS receptor subunits are returned to the cytoplasm after completion of the import reaction is still unknown. Export of karyopherin β is faster and therefore apparently distinct from that of karyopherin α ([@B26]; [@B44]). Both subunits are too large to return to the cytoplasm by simple diffusion and must migrate against a concentration gradient since the NLS receptor resides mostly in the cytoplasm. These observations suggest that they probably require active reexport. It is also clear that the mechanism of nuclear exit of karyopherin α must be different from its entry, as it returns to the cytoplasm without the NLS-bearing protein. Consistent with this, the importin β--binding domain (IBB domain) of karyopherin α is responsible for nuclear entry of the NLS receptor α subunit but does not mediate its export ([@B27]; [@B67]).

To study the requirements for nucleocytoplasmic shuttling of the NLS receptor α subunit in vivo, we used two forms of this protein, Rch1~33--529~ and Rch1~244--529~. Both were originally identified through their interaction with the RAG-1 recombination-activating protein ([@B12]) and have been shown to interact directly and specifically with NLSs ([@B12]; [@B19]). Rch1~33--529~ was reported to substitute for karyopherin α1 in an in vitro nuclear import assay ([@B44]), whereas Rch1~244--529~ inhibited nuclear transport of HIV-1 matrix protein when coexpressed in human 293 cells with HIV-1 matrix protein cDNA ([@B19]) and also inhibited RAG-1--mediated recombination in vivo ([@B12]). The mechanism of this inhibition is not known.

We show here that recycling of Rch1 to the cytoplasm is dependent on a nuclear export signal within residues 207 and 217 and on temperature. Loss of RCC1 activity leads to accumulation of the receptor in the nuclei of microinjected tsBN2 cells, although RCC1 is not necessary for the export reaction itself. We propose that the RCC1-catalyzed exchange of GDP for GTP on Ran is necessary to destabilize or disassemble the import complex and is therefore required for recycling of karyopherin α to the cytoplasm.

Materials and Methods
=====================

Plasmids and Proteins
---------------------

Bacterial expression constructs for human Rch1 were derived by subcloning the Rch1 cDNAs coding for amino acids (aa) 33--529 or aa 244--529 ([@B12]) from a pET21a vector into pET19a using NdeI and XhoI sites from the pET19a multiple cloning site. The resulting fusion constructs contained NH~2~-terminal T7- and His-tags. The Rch1 cDNA encoding for aa 185--529 ([@B12]) was cloned from a yeast expression vector ([@B12]) into the pET21a vector using EcoRI and XhoI restriction sites and subsequently into the pET19a vector using NdeI and XhoI restriction, resulting in a construct analogous to that for aa 33--529 or aa 244--529. For nuclera export signal (NES)-Rch1 constructs, the following oligonucleotides were used: 5′-TAT GCT CCC TCC TCT AGA ACG ACT CAC GCT ACA and 5′-TAT GTA GCG TGA GCT GTT CTA GAG GAG GGA GCA for *HIV*NES-Rch1~244--529~; 5′-TAT GGC AGT GGA TCC ACT GTT GGC TCT CCT TGC AGT TCC TCA and 5′-TAT GAG GAA CTG CAA GGA GAG CCA ACA GTG GAT CCA CTG CCA for *Rch1*NES-Rch1~244--529~; 5′-TAT GGC AGT GGA TCC ACT GGC AGC TGG ACT TGC AGT TCC TCA and 5′-TAT GAG GAA CTG CAA GTC CAG CTG CCA GTG GAT CCA CTG CCA for *Rch1*nes-Rch1~244--529~. They were constructed by annealing the two complementary oligonucleotides and cloning them into the NdeI site of pET19a containing the Rch1~244--529~ cDNA. Correct orientation of the inserted fragment was verified by DNA sequencing. The karyopherin β cDNA in pET30a ([@B9]) was a generous gift from S. Adam (Northwestern University, Chicago, IL). Ran wt cDNA ([@B57]) was cloned from pET9c into pET15a using NdeI and BamHI restriction. The RCC1 cDNA ([@B52]) was cloned from pET3b (T. Dobner, University of Regensburg, Regensburg, Germany) into the pET15a vector via NdeI and BamHI restriction sites.

Maltose binding protein (MBP)--Rch1 fusion constructs were obtained by PCR amplifying DNA encoding Rch1 residues 197--221 with the primers 5′-TTT GAA TTC GAC TTG GTT ATT AAG TAC GGT G and 5′-TTT TCT AGA TAA AGA TGA CAT ATC AGG AAC TG and residues 218--244 using the primers 5′-TTT GAA TTC ATG TCA TCT TTA GCA TGT GGC and 5′-TTT TCT AGA GGT GCA GGA TTC TTG TTG C. The cDNA encoding Rch1~33--529~ in pET19 served as the template. The PCR fragments were cloned into the pMal-Vector (New England Biolabs, Beverly, MA) using EcoRI and XbaI restriction sites. The DNA fragments were sequenced and plasmids containing the correct sequence were transformed into BL21 bacteria for expression.

SV40 T-antigen was purified from insect cells as described by [@B63].

Bacterial Expression and Purification of Proteins
-------------------------------------------------

To purify nearly full-length (aa 33--529) and truncated (aa 244--529) Rch1 peptides, Ran, RCC1, and karyopherin β, the corresponding pET plasmids were transformed into *Escherichia coli* BL21 (DE3) containing the pLys plasmid. Bacteria were grown in 1000 ml Luria-Bertani broth to an OD~600~ of 0.7 at 30°C (37°C for Ran wt and RCC1) and expression was induced by addition of 2 mM IPTG for 3 h. Cells were harvested by centrifugation and frozen in 0.2 M Tris-HCl, pH 8.0, 0.5 M NaCl, 20 μg/ml leupeptin, 2 mM PMSF, and 1 mg/ml aprotinin. Cells were thawed at 37°C and disrupted by ultrasonification after a 15-min incubation at 4°C. To the cleared supernatant of the cell lysates, imidazole, pH 7.6, was added to a final concentration of 30 mM and the solution was loaded on 0.5 ml Ni-NTA-Sepharose (Qiagen, Chatsworth, CA) equilibrated in 0.5 M NaCl and 30 mM imidazole, pH 7.6. After extensive washing with 30 and 60 mM imidazole, pH 7.6, and 0.5 M NaCl, proteins were eluted by step elution with 0.5 M imidazole, pH 7.0, and 0.5 M NaCl, and pooled fractions were dialyzed overnight against 20 mM Hepes/KOH, pH 7.6 (Rch1 derivatives, Ran, karyopherin β), or 20 mM Tris-HCl, pH 7.6 (RCC1), 10% glycerol, and 5 mM mercaptoethanol.

Rch1~185--529~, *Rch1*NES-Rch1~244--529~, *Rch1*nes-Rch1~244--529~, and *HIV*NES-Rch1~244--529~ were purified as insoluble proteins. pET19 plasmids containing the corresponding genes were transformed into BL21 (DE3). Expression of the proteins, harvesting, and disruption of the cells were performed as described above. The cell suspension was centrifuged, and proteins were solubilized from the cell pellet in 8 M urea according to [@B55]. Solubilized proteins were dialyzed to remove the urea, and the protein-containing solution was applied to Ni-NTA-agarose as described above. The eluate was adjusted to 5% glycerol and then dialyzed against 20 mM Hepes/KOH, pH 7.6, 10% glycerol, and 5 mM mercaptoethanol.

MBP fusion proteins were expressed and purified according to a New England Biolabs protocol (1994). After purification, proteins were dialyzed against 20 mM Hepes/KOH, pH 7.6, 10% glycerol, and 5 mM mercaptoethanol.

Cell Culture
------------

BHK21 ([@B64]), tsBN2 cells, a temperature-sensitive mutant line derived from BHK21 cells ([@B50]), and Vero cells ([@B16]) were grown in DME (GIBCO BRL, Gaithersburg, MD) supplemented with antibiotics, 10% FCS (5% for BHK21 cells) (GIBCO BRL), and (for Vero cells) nonessential amino acids (GIBCO BRL) in a humidified incubator at 37°C (Vero) or 33.5°C (tsBN2 and BHK21) under a 10% CO~2~ atmosphere.

Microinjection
--------------

For microinjection experiments, cells were plated for at least 24 h (Vero) or 36 h (tsBN2 and BHK21) before microinjection on glass coverslips. A microinjector and a manipulator (models 5246 and 5171, respectively; Eppendorf Scientific, Inc., Madison, WI) mounted on an inverted microscope (model IM35; Carl Zeiss, Oberkochen, Germany) were used to deliver samples. All proteins were used at a concentration of 2--4 mg/ml and the solutions were centrifuged for 30 min at 14,000 *g* before injection. Microinjection needles were pulled from glass capillaries (Clark Electromedical Instruments, Reading, UK) on an automatic pipette puller (Zeitz Instruments, Augsburg, Germany).

Immunofluorescent Staining
--------------------------

Microinjected cells were washed three times with PBS, fixed in 4% ice-cold paraformaldehyde in PBS for 15 min, permeabilized for 15 min in 0.2% Triton X-100, and blocked for 1 h in 10% FCS in PBS. T7-tagged Rch1 proteins were visualized by staining for 2 h at room temperature with a mouse monoclonal anti-T7 antibody (Novagen Corp., Madison, WI) at a 1:500 dilution and a Cy3-linked secondary anti--mouse antibody (Jackson ImmunoResearch Laboratories, West Grove, PA) at 1:200 for 1 h at room temperature. MBP fusion proteins were detected with a polyclonal anti-MBP serum (New England Biolabs) at a 1:100 dilution followed by a Cy3-conjugated anti--rabbit antibody (Jackson ImmunoResearch Laboratories) at 1:200 for 1 h at room temperature. The coverslips were mounted in 90% glycerol containing 0.1 mg/ml paraphenylenediamine in PBS (Johnson and Araujo, 1981) and viewed on a fluorescence microscope (model Axiovert 35; Carl Zeiss) using a 63× objective.

Quantification
--------------

Quantification was done by capturing images of fluorescent cells with a digital camera (CCD camera, model C 4880; Hamamatsu Phototonics, Bridgewater, NJ). The amount of fluorescence in each fixed cell or in the nucleus of the cell was evaluated using the Image-/MetaMorph Imaging System (Universal Imaging Corp., West Chester, PA). Background measurements were obtained by evaluating the fluorescence of noninjected fixed cells or nuclei.

In Vitro Assembly of NLS Receptor--Import Substrate Complexes
-------------------------------------------------------------

Assembly of complexes was performed according to an ELISA protocol ([@B22]). ELISA immunoplates (Nunc, Rochester, NY) were coated with 2 μg of karyopherin β in 50 μl of PBS for 2 h at room temperature, followed by saturation of residual nonspecific binding sites with 3% BSA in PBS for 1 h at room temperature. The soluble proteins were added in the following amounts: 1 μg of Rch1~33--529~, 1 μg SV-40 T-antigen, 2 μg of Ran (RanGDP, RanGTP, or RanGTP-γS), and 2 μg of RCC1, as indicated in the figure legend. Additionally, the corresponding nucleotides were present at 2 mM. The binding reaction was performed for 2 h at room temperature in binding buffer ([@B5]) (20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM DTT, and 5 mM MgCl~2~). The plates were washed three times briefly and three times for 10 min each, and either anti--T-antigen antibody Pab101 ([@B30]) (1 μg/ well in 50 μl of PBS) or anti-T7 antibody (0.1 μl/well in 50 μl of PBS) was added and incubated overnight, followed by washing of the plates as above and incubation with 1 μl/well peroxidase-coupled anti--mouse secondary antibody (Jackson ImmunoResearch) in 100 μl of PBS for 1 h at room temperature. Plates were washed again and the ELISA was developed by adding 100 μl of peroxidase substrate (50 mM potassium phosphate, pH 5.7, 0.03% H~2~O~2~, 2 mM 2,2′-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid; Sigma Chemical Co., St. Louis, MO) for 5 min. The absorbance of the reaction product was measured at 405 nm using a reference filter at 595 nm in an ELISA reader (model MR5000; DYNEX Technologies, Chantilly, VA).

Results
=======

Subcellular Localization of Rch1~33--529~ and Rch1~244--529~
------------------------------------------------------------

To determine the subcellular localization of Rch1~33--529~ and Rch1~244--529~, each protein was microinjected into the cytosol of Vero cells. The cells were either fixed immediately after injection or after a 2.5-h incubation at 37°C. The exogenous Rch1 was visualized by staining its T7-tag with anti-T7 antibodies. As shown in Fig. [1](#F1){ref-type="fig"} *A*, *a* and *b*, Rch1~33--529~ was localized predominantly in the cytoplasm at both time points. Although cells injected with Rch1~244--529~ showed cytoplasmic staining immediately after injection (Fig. [1](#F1){ref-type="fig"} *A*, *c*), strong nuclear staining was observed 2.5 h later (Fig. [1](#F1){ref-type="fig"} *A*, *d*). The time course of nuclear uptake of the two proteins was followed by injecting cells with either Rch1~33--529~ or Rch1~244--529~, fixing them at various time points as indicated (Fig. [1](#F1){ref-type="fig"} *B*), and determining the amount of nuclear fluorescence as a percentage of the total cell fluorescence in the injected cells. The graph shows that the fraction of nuclear Rch1~33--529~remained at ∼20% over a period of 2.5 h, consistent with the predominantly cytoplasmic importin α observed in *Xenopus* cells ([@B27]). However, nuclear staining of Rch1~244--529~increased slowly from 12 to 38% over the same period of time. Since nuclear protein import took place over the entire 2.5-h period, these results suggest that Rch1~33--529~ was rapidly recycled to the cytoplasm, but Rch1~244--529~ was not.

Export of Rch1~33--529~ and Rch1~244--529~
------------------------------------------

To address the question of whether nuclear accumulation of Rch1~244--529~could be due to a defect in recycling of this protein to the cytoplasm, export of Rch1~33--529~ and Rch1~244--529~ was examined more closely. The purified proteins were microinjected into the nuclei of Vero cells, and the cells were fixed either immediately after injection or after a 30-min incubation at 37°C. Fig. [2](#F2){ref-type="fig"} *A* shows that cells microinjected with Rch1~33--529~ showed almost exclusively nuclear staining initially (Fig. [2](#F2){ref-type="fig"} *A*, *a*) and strong cytoplasmic staining after a 30-min incubation (Fig. [2](#F2){ref-type="fig"} *A*, *b*). In sharp contrast, the staining pattern of cells injected with Rch1~244--529~ was nuclear at both time points (Fig. [2](#F2){ref-type="fig"} *A*, *c* and *d*). Analysis of the Rch1 export kinetics (Fig. [2](#F2){ref-type="fig"} *B*) demonstrated a rapid decrease of nuclear fluorescence in cells injected with Rch1~33--529~. However, the amount of nuclear Rch1~244--529~ fluorescence remained constant over the entire time period (Fig. [2](#F2){ref-type="fig"} *B*). These observations indicate that Rch1~33--529~ injected into the nuclei of Vero cells was rapidly exported, whereas Rch1~244--529~ was not. The results also suggest that a polypeptide sequence between aa 1 and 244 of Rch1 may be necessary to allow nuclear export of Rch1.

Another Rch1 deletion mutant, Rch1~185--529~, was used to narrow down the region that might contain the information necessary for nuclear export of the NLS receptor subunit. Rch1~185--529~ was injected into the nuclei of Vero cells, and the cells were fixed and stained either immediately after injection or after a 30-min incubation at 37°C. Fig. [3](#F3){ref-type="fig"} *A* shows that shortly after injection, Rch1~185--529~ was still in the nucleus of injected cells (Fig. [3](#F3){ref-type="fig"} *A*, *a*), whereas 30 min later, translocation to the cytoplasm had occurred (Fig. [3](#F3){ref-type="fig"} *A*, *b*). Comparison of the export kinetics of Rch1~185--529~and Rch1~33--529~(Fig. [3](#F3){ref-type="fig"} *B*) confirmed that the rate of export of Rch1~185--529~was comparable to that of Rch1~33--529~. These results support the idea that the sequence between aa 185 and 244 of Rch1 is necessary to direct nuclear export of Rch1.

Rch1 Contains a Nuclear Export Signal
-------------------------------------

To examine the possibility that a nuclear export signal could reside in the region between amino acids 185--244, the cDNA sequences of the mouse, human, *Xenopus*, and yeast NLS receptor α subunit were first compared and screened for conserved leucines in a hydrophobic environment, a motif common to several nuclear export sequences ([@B21]; [@B49]). The region between aa 207 and 217 met these characteristics: DPL*PL* **L** *A* **L**LAVPD. The amino acids shown in bold are conserved and amino acids shown in italics are similar among the species mentioned above.

To determine which sequence in the region between aa 185--244 was necessary to direct nuclear export of Rch1, two DNA fragments from this region were chosen, one including the putative NES (coding for aa 197--217) and a second, downstream from the putative NES (coding for aa 218--244). The fragments were obtained by PCR and cloned into the pMal-vector to allow expression of a fusion construct between the MBP, a 42-kD bacterial protein, and the Rch1 cDNA fragment.

The proteins MBP~197--217~ and MBP~218--244~ were then injected into the nuclei of BHK21 cells, and the cells were fixed at different time points after injection to monitor the export reaction. As a control, MBP was also injected. Immunofluorescence was performed using a polyclonal anti-MBP serum and a secondary antibody coupled to Cy3. The amount of nuclear fluorescence was measured using quantitative fluorescent microscopy.

The fluorescent micrographs (Fig. [4](#F4){ref-type="fig"} *A*) show that both MBP and MBP~218--244~ were nuclear at the 0-min (Fig. [4](#F4){ref-type="fig"} *A*, *a* and *c*) and the 10-min (Fig. [4](#F4){ref-type="fig"} *A*, *b* and *d*) time points. In contrast, cells injected with MBP~197--217~ showed nuclear staining only at the 0-min time point (Fig. [4](#F4){ref-type="fig"} *A*, *e*) and cytoplasmic staining after a 10-min incubation (Fig. [4](#F4){ref-type="fig"} *A*, *f*). The export kinetics shown in Fig. [4](#F4){ref-type="fig"} *B* confirm that neither MBP nor MBP~218--244~ were exported over the time period monitored. However, MBP~197--217~ was very rapidly exported from the nucleus to the cytoplasm. We therefore conclude that the amino acids 197--217, encompassing the putative NES, were sufficient to direct nuclear export of MBP.

In another set of experiments, the putative nuclear export signal was directly investigated. A cDNA fragment coding for amino acids 207--217 was cloned into the Rch1~244--529~ pET19-vector, fusing residues 207--217 to the amino terminus of Rch1~244--529~ and resulting in *Rch1*NES-Rch1~244--529~. Similarly, a mutant form of the putative NES with the conserved leucines 110 and 112 exchanged for alanine and glycine (L110A, L112G) was fused to the amino terminus of Rch1~244--529~, resulting in *Rch1*nes-Rch1~244--529~. As a positive control for this experiment, sequences encoding the NES of the HIV Rev protein were cloned into the same site of Rch1~244--529~. It was shown earlier that the Rev NES, when coupled to BSA, promoted its export after injection of NES-BSA into *Xenopus* oocytes or mammalian cell nuclei ([@B17]).

Nuclear export of *Rch1*NES-Rch1~244--529~, *Rch1*nes-Rch1~244--529~, and *HIV*NES-Rch1~244--529~ was then assayed after injection into nuclei of Vero cells. Cells were fixed either at a 0-min time point or 30 min later, followed by immunofluorescent staining of the exogenous protein. The fluorescent micrographs in Fig. [5](#F5){ref-type="fig"} *A* demonstrate that cells injected with either *Rch1*NES-Rch1~244--529~ or *HIV*NES-Rch1~244--529~ showed nuclear staining immediately after injection (Fig. [5](#F5){ref-type="fig"} *A*, *a* and *c*) and cytoplasmic staining after a 30-min incubation (Fig. [5](#F5){ref-type="fig"} *A*, *b* and *d*), but cells injected with *Rch1*nes-Rch1~244--529~ showed nuclear staining at both time points (Fig. [5](#F5){ref-type="fig"} *A*, *e* and *f*). To monitor the time course of the export reaction, cells were fixed at different time points after injection, and immunofluorescence was performed using the anti-T7 antibody. The amount of nuclear fluorescence was determined and plotted against time after microinjection. As a control, Rch1~244--529~ was also injected. The export kinetics in Fig. [5](#F5){ref-type="fig"} *B* show that although Rch1~244--529~ and *Rch1*nes-Rch1~244--529~were not exported, *Rch1*NES-Rch1~244--529~was exported at a rate very similar to that of *HIV*NES-Rch1~244--529~. These results demonstrate that export of the deletion mutant was restored not only by the established nuclear export signal of HIV-Rev ([@B17]), but also by amino acids 207--217 of Rch1, indicating that they function as a nuclear export signal. Leucines 110 and 112 of Rch1 appear to be necessary for this function.

Export of Rch1 Is Temperature Dependent
---------------------------------------

If export of Rch1 from the nucleus depends on the nuclear export signal that is deleted in Rch1~244--529~, one might also expect the export process, like the nuclear import process, to be temperature dependent. To address this question, we tested export of the NLS receptor α subunit at 0°C. Vero cells were shifted to 0°C immediately before nuclear microinjection of Rch1~33--529~, and Rch1~244-529~and then incubated on ice for various time periods. Cells were fixed and the exogenous tagged Rch1 was visualized by immunofluorescence. Cells injected with both forms of Rch1 showed nuclear staining not only immediately after injection (Fig. [6](#F6){ref-type="fig"} *A*, *a* and *c*), but also after a 30-min incubation on ice (Fig. [6](#F6){ref-type="fig"} *A*, *b* and *d*). Quantitative evaluation of nuclear fluorescence in cells injected with Rch1~33--529~ and Rch1~244--529~confirmed that the intensity of nuclear fluorescence was constant over the 30-min time period (Fig. [6](#F6){ref-type="fig"} *B*). These results support the idea that recycling of Rch1 is temperature dependent and show that neither Rch1~33--529~ nor Rch1~244--529~can exit the nucleus by simple diffusion.

Role of RCC1 in Receptor Recycling
----------------------------------

Addition of RanGTP to the heterodimeric complex of karyopherin α and β leads to the dissociation of the heterodimer in vitro ([@B58]; [@B28]). The fact that the nuclear protein RCC1 is the only known Ran guanine exchange factor, and plays a role in nuclear protein import in vivo ([@B65]; [@B14]), suggested that RCC1 could be involved in the release of Rch1 from the import complex by providing RanGTP. Since the disassembly of the import complex must be a prerequisite for the recycling of the import factors, RCC1 would then indirectly affect the shuttling of the NLS receptor α subunit. To investigate the possible effect of RCC1 on receptor recycling, we used tsBN2 cells, mutant derivatives of BHK21 cells that express thermolabile RCC1 (for review see [@B13]). To compare shuttling of Rch1 in the presence and absence of RCC1, Rch1~33--529~was injected into the cytoplasm of tsBN2 cells. The cells were then fixed immediately or incubated for 4 h at either the restrictive or permissive temperature. The subcellular distribution of Rch1~33--529~ was then determined by immunofluorescent staining. Fig. [7](#F7){ref-type="fig"} *A* shows that in the presence of RCC1, cells displayed the predominantly cytoplasmic staining typical of injected Rch1~33--529~(Fig. [7](#F7){ref-type="fig"} *A*, *a* and *b*). In contrast, Rch1 was predominantly nuclear in the absence of RCC1 (Fig. [6](#F6){ref-type="fig"} *A*, compare *b* \[33.5°C\] and *d* \[39.5°C\]).

The import kinetics of Rch1 in the presence of RCC1 demonstrated that Rch1~33--529~ was mostly cytoplasmic in tsBN2 cells incubated at 33.5°C (Fig. [7](#F7){ref-type="fig"} *B*). The nuclear accumulation of Rch1 in the absence of RCC1 (Fig. [7](#F7){ref-type="fig"} *B*) demonstrates that RCC1 is required directly or indirectly for recycling of Rch1 to the cytoplasm. In a control experiment using the parental cell line BHK21, Rch1~33--529~was mostly cytoplasmic at both temperatures (Fig. [7](#F7){ref-type="fig"} *B*), demonstrating that the altered distribution of Rch1 at the restrictive temperature is caused by the RCC1 mutation rather than by the elevated temperature.

RCC1 Is Not Required for Export of Rch1
---------------------------------------

Two simple alternatives can be proposed for the role of RCC1 in receptor recycling. In one model, transport of Rch1 back into the cytoplasm might require RanGTP generated by RCC1. Loss of RCC1 would lead to depletion of RanGTP in the nucleus, and subsequently to a defect in receptor recycling. If this idea were correct, export of Rch1 should be inhibited when Rch1 was injected into nuclei of tsBN2 cells that had been incubated at 39.5°C before microinjection and therefore lacked active RCC1. In the other model, RCC1 would act at a step before export of Rch1, for example in the disassembly of the import complex. Rch1 accumulated in tsBN2 nuclei at the restrictive temperature after cytoplasmic injection would then be part of a nondisassembled import complex. If this possibility were correct, free Rch1 injected directly into the nucleus should be exported in a fashion independent of RCC1.

To differentiate between these two possibilities, we injected Rch1~33--529~into the nuclei of tsBN2 cells that had been incubated at the permissive and restrictive temperatures. The cells were fixed either immediately after injection (Fig. [8](#F8){ref-type="fig"} *A*, *a* and *c*) or 30 min later (Fig. [8](#F8){ref-type="fig"} *A*, *b* and *d*), and Rch1~33--529~ was visualized by immunofluorescence. At both temperatures, Rch1~33--529~injected into the nuclei was found in the cytoplasm after a 30-min incubation. The time course (Fig. [8](#F8){ref-type="fig"} *B*) shows clearly that nuclear export kinetics of Rch1 were identical in the presence or absence of RCC1. In a control experiment in BHK21 cells, Rch1 export kinetics were also identical at 33.5 and 39.5°C (Fig. [8](#F8){ref-type="fig"} *B*). No export of Rch1 to the cytoplasm was observed at 0°C (data not shown), consistent with the temperature dependence of the Rch1 export reaction (Fig. [6](#F6){ref-type="fig"}). These results rule out a requirement for RCC1 in the export reaction itself and support the idea that it is required in an earlier step of receptor recycling.

RCC1 Destabilizes the NLS Receptor/Substrate Complex In Vitro
-------------------------------------------------------------

The results presented in Fig. [8](#F8){ref-type="fig"} suggested that RCC1 was not required for nuclear export of free Rch1~33--529~ in vivo, but rather for a step before export. One step that must occur before Rch1 recycling is the disassembly of the NLS receptor αβ complex with the imported cargo protein. RanGTP was reported to disassemble the NLS receptor αβ complex in vitro ([@B58]) by binding to karyopherin β at a binding site that overlaps with the karyopherin α binding site ([@B46]; [@B28]). These results supported the idea that the role of RCC1 might be to destabilize an NLS receptor/substrate complex in the nucleus.

To develop a method to test this possibility, we first assembled NLS receptor/substrate complexes using purified proteins in a solid phase assay. Karyopherin β and, as a control, BSA were immobilized on ELISA plates and soluble Rch1~33--529~ was added. After washing, bound Rch1~33--529~was detected using the anti-T7 antibody and a peroxidase-coupled secondary antibody. Fig. [9](#F9){ref-type="fig"} *A* shows that Rch1~33--529~was bound in the presence of karyopherin β, but not in the presence of BSA, indicating that Rch1~33--529~bound specifically to karyopherin β. To test whether the immobilized Rch1~33--529~/karyopherin β complexes were able to bind T-antigen as an NLS-bearing protein, we immobilized karyopherin β in the ELISA plate and then added either T-antigen alone or T-antigen together with Rch1~33--529~. Bound T-antigen was detected using a specific monoclonal antibody and a peroxidase-coupled second antibody. Fig. [9](#F9){ref-type="fig"} *B* shows that bound T-antigen was detectable in the presence of karyopherin β and Rch1~33--529~ but not with karyopherin β alone, indicating the assembly of an αβ NLS receptor complex with the transport substrate T-antigen.

The influence of RanGDP and RanGTP on the assembly or stability of the NLS receptor/substrate complexes was then tested. RanGDP in the presence of GDP and Mg^2+^ did not affect the assembly of NLS receptor/substrate complexes (Fig. [9](#F9){ref-type="fig"} *C*, compare column *1* with column *3*). When RanGTP was added, NLS receptor/T-antigen complex formation was slightly reduced in the presence of Mg^2+^ and GTP (Fig. [9](#F9){ref-type="fig"} *C*, column *5*). If Ran was loaded with GTPγ-S, a nonhydrolyzable GTP analogue, complex formation was strongly inhibited in the presence of Mg^2+^ and GTPγ-S (Fig. [9](#F9){ref-type="fig"} *C*, compare columns *5* and *6*). However, if RCC1 and GTP were present, NLS receptor complex formation was inhibited by ∼60% (Fig. [9](#F9){ref-type="fig"} *C*, column *7*), while RCC1 in the presence of GDP had no effect (Fig. [9](#F9){ref-type="fig"} *C*, column *4*). These results indicate that when RanGTP was added without RCC1, GTP hydrolysis on Ran occurred, but GDP bound to Ran was not exchanged for GTP in the presence of Mg^2+^ ([@B5]), and therefore did not destabilize or impair formation of the NLS receptor/T-antigen complex. On the other hand, when RanGTP, RCC1, and GTP were added, GDP bound to Ran after GTP hydrolysis was exchanged for GTP.

These results confirm that RanGTP prevents formation of the NLS receptor complex or induces its disruption as reported ([@B58]; [@B46]) and demonstrate that RCC1-catalyzed exchange of GDP for GTP on Ran inhibited formation of the NLS receptor/ substrate complex or dissociated the existing complexes.

Discussion
==========

Karyopherin α Sequences Required for Recycling to the Cytoplasm
---------------------------------------------------------------

In this report, we have investigated the requirements in vivo for recycling of the α subunit of the NLS receptor (Rch1) from the nucleus to the cytoplasm. Rch1 was found predominantly in the cytoplasm with only ∼20% of the exogenous α subunit localized to the nucleus in Vero cells and ∼30% in tsBN2 cells. These results are in accordance with the subcellular distribution of the endogenous α subunit, which was found in higher concentrations in the cytoplasm than in the nucleus in *Xenopus* X1177 cells ([@B27]). This similarity indicates that Rch1~33--529~behaves in these assays much like the endogenous α subunit.

The importin β--binding domain of karyopherin α ([@B27]; [@B67]) was mapped to residues 1--65 of importin α and required aa 21--65 or 1--52. In contrast, Rch1~33--529~ was reported to support nuclear import in vitro as efficiently as full-length karyopherin α1 ([@B44]), and even a karyopherin α1 mutant lacking the first 49 amino acids was reported to bind to karyopherin β in vitro, albeit with reduced efficiency ([@B45]). Another group observed nuclear entry of Rch1~33--529~ in vivo ([@B19]), consistent with nuclear import activity. The experimental variables that give rise to the discrepancies between these reports have not been resolved. However, our experiments showed nuclear entry and exit of Rch1~33--529~in vivo (Figs. [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}, and [7](#F7){ref-type="fig"}), as expected for an α subunit active in nuclear protein import, and our in vitro binding assays confirmed interaction of Rch1~33--529~with both karyopherin β and an NLS-bearing cargo protein as expected for an NLS receptor complex (Fig. [9](#F9){ref-type="fig"}).

The IBB domain is completely absent in the Rch1~244--529~ deletion mutant, precluding its activity in nuclear protein import. Nevertheless, nuclear entry of this protein was still observed. One possible explanation for this apparent contradiction is that Rch1~244--529~ might enter the nucleus piggyback on a protein with more than one NLS. Rch1~244--529~ is capable of binding to NLSs in a transport substrate ([@B12]), and a substrate with multiple NLSs could still interact with endogenous karyopherin α after binding one molecule of Rch1~244--529~. The endogenous NLS receptor α subunit could thus mediate the transport reaction. However, our data do not rule out the possibility that Rch1~244--529~ could enter the nucleus via diffusion.

In our experiments, Rch1~244--529~was found to accumulate in the nuclei over a 2.5-h period (Fig. [1](#F1){ref-type="fig"}), while [@B19] reported that Rch1~244--529~was exclusively cytoplasmic at ∼48 h after the corresponding cDNA was transfected into 293S cells. This discrepancy might be explained by the very different times at which localization was assayed. When cells were microinjected with cDNA encoding Rch1~244--529~and incubated for extended time periods, nuclear accumulation of the protein was initially observed for ∼4--5 h, but after that nuclear staining was reduced (data not shown). Slow leaking from the nucleus has been observed with other proteins. For example, pyruvate kinase injected into the nuclei of *Xenopus* oocytes was gradually transported out of the nucleus ([@B62]).

Compared with the nuclear export of pyruvate kinase, nuclear export of Rch1~33--529~ was very rapid (Fig. [2](#F2){ref-type="fig"}). The high concentration of NLS receptor α subunit in the cytoplasm, which probably depends on the fast export reaction from the nucleus, could be very important in maintaining directionality in the import reaction. Rch1~244--529~, however, proved to be deficient in this fast nuclear export reaction (Fig. [2](#F2){ref-type="fig"}). The fast nuclear exit of Rch1 is mediated by a sequence in the region between aa 207 and 217 (Figs. [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}) that probably carries an NES since the HIV Rev NES fused to Rch1~244--529~ restored nuclear export of the deletion mutant to a very similar extent as aa 207--217 (Fig. [5](#F5){ref-type="fig"}). Typically, NESs contain several Leu-residues and are rich in hydrophobic amino acids (for review see [@B21]; [@B49]). The region 207--217 in Rch1 shows similar characteristics: Rch1, DPL*PL* **L** *A* **L**LAVPD; PKI NES, LALKLAGLDI ([@B68]); and Rev NES, LPPLERLTL ([@B17]; [@B68]). Interestingly, the leucine residues indicated in bold are conserved among human Rch1, mouse importin, *Xenopus* importin 1, and yeast SRP1p α subunits, and residues indicated in italics are similar ([@B69]; [@B12]; [@B24]; [@B31]), consistent with their probable importance in Rch1 function. We have shown here that the conserved leucines are necessary for the NES activity of amino acids 207--217.

The pathway of karyopherin α recycling must be different from that for its entry into the nucleus to achieve accumulation of nuclear proteins in the nucleus. One mechanistic difference probably lies in the proteins that accompany karyopherin α during the transport through the pore in the import and export reactions. Import of karyopherin α is mediated by karyopherin β, whereas export is not, since the IBB domain of karyopherin α supports only nuclear entry, but not exit of karyopherin α ([@B27]; [@B67]). Our data indicate that Rch1 export depends on an NES and on energy, suggesting a receptor-mediated export reaction. However, the putative export receptor and other proteins required for recycling remain to be identified. Interestingly, [@B3] reported that a yeast mutant that lacked Nup120p and displayed defects in mRNA export also accumulated importin α in the nucleus, pointing to a possible role for NPC proteins in receptor recycling.

A Role for RCC1 in Rch1 Recycling to the Cytoplasm
--------------------------------------------------

RCC1 was also found to be a requirement for the recycling of the NLS receptor α subunit. Loss of RCC1 in tsBN2 cells led to nuclear accumulation of cytoplasmically injected Rch1~33--529~(Fig. [7](#F7){ref-type="fig"}). The time course of nuclear accumulation of Rchl~33--529~ depicted in Fig. [7](#F7){ref-type="fig"} *B* shows that when tsBN2 cells were shifted to the restrictive temperature directly after the injection, the Rch1 distribution was predominantly cytoplasmic for about the first hour. By 2 h after the shift-up, however, the intensity of nuclear staining of Rch1~33--529~ was markedly increased and continued to increase over the time period monitored. We speculate that during the first hour after shift-up, active RCC1 was still present. This time course is consistent with the observation that inhibition of nuclear protein import in vivo in tsBN2 cells was first detectable after 2 h at the restrictive temperature ([@B14]). Trapping of Rch1 in the nucleus, as observed here, may well be responsible for the nuclear protein import defect of tsBN2 cells at the restrictive temperature.

On the other hand, export of free receptor from the nucleus to the cytoplasm was not dependent on RCC1 (Fig. [8](#F8){ref-type="fig"}). Since inactivation of the RCC1 homologue prp20 in yeast also resulted in nuclear accumulation of the yeast Rch1 homologue (Koepp at al., 1996), the authors speculated that RanGTP supplied by prp20 might be necessary for the exit of the yeast NLS receptor α subunit from the nucleus. However, we demonstrate here that at least for tsBN2 cells, the exit event itself was not affected by the loss of RCC1 (Fig. [8](#F8){ref-type="fig"}). While this manuscript was under revision, [@B59] independently demonstrated that RCC1 was not necessary for nuclear export of an NES-bearing protein. Nevertheless, RanGTP did appear to be necessary for export. These findings are consistent with our proposal that RCC1 plays a role in an earlier step of NLS receptor recycling.

RanGTP, but not RanGDP, was reported to destabilize the karyopherin αβ heterodimer in vitro ([@B58]; [@B46]). We confirm this result here using a solid phase assay and show that Ran, GTP, and RCC1 release an NLS-bearing protein from an NLS receptor/substrate complex or prevent formation of these complexes (Fig. [9](#F9){ref-type="fig"} *C*). These results, taken together with our in vivo data, suggest that RCC1 could induce the disassembly of the import complex by providing RanGTP, which dissociates karyopherin β from the import complex, thereby lowering the affinity of karyopherin α to NLSs ([@B58]). RanGTP will therefore facilitate the release of the imported protein from the NLS receptor α subunit, which in turn would be a prerequisite for the recycling of the α subunit. Interaction of the imported protein with other nuclear proteins or DNA, and/or association of karyopherin α with other proteins involved in the recycling process, could then promote the dissociation of import substrate from the α subunit.
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(*A*) Rch1~244--529~ accumulates in the nuclei of Vero cells in vivo. Vero cells were injected into the cytoplasm with either Rch1~33--529~ (*a* and *b*) or Rch1~244--529~ (*c* and *d*) and fixed immediately (*a* and *c*) and 2.5 h (*b* and *d*) after injection. Immunofluorescence was performed using an antibody against the T7-tag of the extracellular Rch1 proteins and a Cy3-coupled secondary antibody. Micrographs were taken with a digital camera mounted on a fluorescence microscope. (*B*) Time course of nuclear accumulation of Rch1~244--529~. Vero cells were injected either with Rch1~33--529~ or Rch1~244--529~ and fixed at various time points as indicated on the x-axis. Cells were immunostained, and the amount of Rch1 fluorescence was measured as described in Materials and Methods. The staining of nuclear Rch1 is expressed as the percentage of total cell fluorescence residing in the nucleus and plotted against time after microinjection. For each time point, the average value obtained from 10--20 cells in two to three independent experiments is shown; the standard deviation of the mean is indicated by error bars. Bar, 25 μm.
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(*A*) Rch1~244--529~is defective in nuclear export. Rch1~33--529~ (*a* and *b*) and Rch1~244--529~ (*c* and *d*) proteins were injected into nuclei of Vero cells. Fluorescence micrographs show cells fixed and stained 0 min (*a* and *c*) or 30 min (*b* and *d*) after injection. (*B*) Export kinetics of Rch1. Vero cells were injected into the nucleus with either Rch1~33--529~ or Rch1~244--529~ and incubated for the indicated time periods. Quantification was performed as in Fig. [1](#F1){ref-type="fig"} *B*. Bar, 25 μm.
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(*A*) Rch1~185--529~ is efficiently exported from the nucleus. Rch1~185--529~ was injected into the nuclei of Vero cells, which were fixed and immunostained 0 min (*a*) or 30 min (*b*) later. (*B)* Cells were injected into the nucleus with either Rch1~185--529~or Rch1~33--529~ to compare export kinetics of the two proteins. After injection, cells were fixed and stained. Nuclear fluorescence was determined and plotted against time after microinjection as in Fig. [1](#F1){ref-type="fig"} *B*. Bar, 25 μm.
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(*A*) Export of MBP--Rch1 fusion constructs. BHK21 cells were injected into the nucleus with purified proteins MBP (*a* and *b*), MBP fused to Rchl residues 218--244 (*c* and *d*), or MBP fused to Rchl residues 197--217 (*e* and *f*), fixed 0 min (*a*, *c*, and *e*) or 10 min (*b*, *d*, and *f*) later, and examined by immunofluorescence. (*B*) Export kinetics of MBP--Rch1 fusion constructs. After nuclear injection of MBP, MBP~218--244~, and MBP~197--217~, the cells were fixed and immunostained using an anti-MBP polyclonal serum. Nuclear fluorescence at different times after injection was determined and plotted against time as in Fig. [1](#F1){ref-type="fig"} *B*. Bar, 25 μm.
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(*A*) Export of Rch1~244--529~ is restored by a nuclear export signal. *HIV*NES-Rch1~244--529~(*a* and *b*), *Rch1*NES-Rch1~244--529~ (*c* and *d*), and *Rch1*nes-Rch1~244--529~ (*e* and *f*) were injected into nuclei of Vero cells. Cells were fixed either at a 0-min time point (*a*, *c*, and *e*) or 30 min later (*b*, *d*, and *f*). Immunofluorescence was performed using an anti-T7 antibody. (*B*) Export kinetics of Rch1~244--529~, *HIV*NES-Rch1~244--529~, Rc*h1*NES-Rch1~244--529~, and *Rch1*nes-Rch1~244--529~. Nuclear fluorescence at different time points after injection was determined as described (Fig. [1](#F1){ref-type="fig"} *B*). Bar, 25 μm.
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(*A*) Export of Rch1 is temperature dependent. Rch1~33--529~and Rch1~244--529~were injected into the nuclei of Vero cells at 0°C. The cells were either fixed (*a* and *c*) or incubated on ice for 30 min and then fixed (*b* and *d*). Cells were immunostained and fluorescent micrographs were taken. (*B*) Export of Rch1 is impaired at 0°C. The graph shows the quantification of the nuclear fluorescence of cells injected into the nucleus with Rch1~33--529~or Rch1~244--529~and incubated on ice as indicated on the x-axis before fixing and immunostaining.
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(*A*) Effect of RCC1 depletion on Rch1 recycling. tsBN2 cells were injected with Rch1~33--529~ into the cytoplasm followed by incubation at 33.5°C (*a* and *b*) or 39.5°C (*c* and *d*). Fluorescence micrographs show the localization of Rch1 in cells that were fixed after 0 min (*a* and *c*) or 4 h (*b* and *d*) of incubation under the conditions indicated. (*B*) Time course of nuclear accumulation of cytoplasmically injected Rch1~33--529~ in the absence and presence of RCC1. tsBN2 and BHK21 cells were injected into the cytoplasm with Rch1~33--529~ and incubated at 39.5°C or, as a control, at 33.5°C for various time periods, fixed and stained. Quantification was done as in Fig. [1](#F1){ref-type="fig"} *B* and the percentage of Rch1 in the nucleus was expressed as a function of time after injection. Bar, 25 μm.
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(*A*) Export of free Rch1 is not dependent on RCC1. Rch1~33--529~was injected into the nuclei of tsBN2 cells preincubated for 4 h at 33.5 or 39.5°C. Cells were fixed and stained immediately after injection (*a* and *c*) or incubated for 30 min before fixing and immunostaining (*b* and *d*). (*B*) Export of free Rch1 is independent of RCC1. tsBN2 and, as a control, BHK21 cells, were incubated for 4 h at 33.5 or 39.5°C before nuclear injection with Rch1~33--529~. For injections at 0°C, cells were first incubated at 33.5°C, but shifted to 0°C immediately before injection. After incubation at the indicated temperatures for the indicated time periods, cells were fixed and stained. Quantification was performed as described in Fig. [1](#F1){ref-type="fig"} *B*. Bar, 25 μm.
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RCC1 inhibits formation of the NLS receptor/substrate complex. (*A*) Karyopherin β was immobilized on an ELISA plate before addition of different amounts of Rch1~33--529~, as indicated on the x-axis of the graph. Plates were washed and Rch1 bound to the solid phase was detected in a colorimetric reaction. (*B*) Karyopherin β was immobilized on ELISA plates. T-antigen was added in the amounts indicated on the x-axis of the graph, either alone or together with Rch1~33--529~. Plates were washed, and the amount of T-antigen bound to the solid phase was determined in a colorimetric reaction. (*C*) Karyopherin β was immobilized on ELISA immunoplates before addition of either Rch1~33--529~and T-antigen (columns *1* and *3--7*) or T-antigen alone (column *2*). The binding reactions were then supplemented with RanGDP and GDP (column *3*); RanGDP, GDP, and RCC1 (column *4*); RanGTP and GTP (column *5*); RanGTP-γS and GTP-γS (column *6*); or RanGTP, GTP, and RCC1 (column *7*). MgCl~2~ was present in all reactions at 5 mM. The T-antigen bound to each solid phase was determined in a colorimetric reaction. The columns depict the mean values from at least two separate experiments; the standard deviation of the mean is indicated by error bars.
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